Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis Bioresearch Establishes US Subsidiary

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis bioresearch today announced it has created a US subsidiary.

The US subsidiary is called Cellectis bioresearch Inc., and is headquartered at the Cambridge Innovation Center in Cambridge, Mass. Cellectis bioresearch, based in Romainville, France, is a subsidiary of Cellectis, and provides tools for genome customization.

The US company will be responsible for promoting Cellectis bioresearch products and services in the US. Eric Merle has been named sales director for the US and will be in charge of recruiting and managing a sales staff. He will report to Luc Selig, vice president of sales and marketing at the French operations.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more